BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 41 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $844,752 | +13.7% | 860,000 | +14.7% | 0.00% | – |
| Q2 2022 | $743,000 | -45.0% | 750,000 | -44.4% | 0.00% | -100.0% |
| Q1 2022 | $1,350,000 | +7.7% | 1,350,000 | +12.5% | 0.00% | 0.0% |
| Q4 2021 | $1,254,000 | +2.1% | 1,200,000 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $1,228,000 | -65.1% | 1,200,000 | -65.5% | 0.00% | -50.0% |
| Q1 2021 | $3,523,000 | -46.6% | 3,481,000 | -43.4% | 0.00% | -50.0% |
| Q4 2020 | $6,595,000 | -14.9% | 6,146,000 | -16.8% | 0.00% | -20.0% |
| Q3 2020 | $7,753,000 | +118.8% | 7,389,000 | +154.8% | 0.01% | +66.7% |
| Q2 2020 | $3,544,000 | -33.8% | 2,900,000 | -43.2% | 0.00% | -40.0% |
| Q1 2020 | $5,352,000 | +0.2% | 5,107,000 | +1.0% | 0.01% | +66.7% |
| Q4 2019 | $5,343,000 | +48.0% | 5,058,000 | +37.7% | 0.00% | 0.0% |
| Q3 2019 | $3,609,000 | -4.1% | 3,672,000 | +1.3% | 0.00% | +50.0% |
| Q2 2019 | $3,762,000 | -31.8% | 3,624,000 | -32.8% | 0.00% | -33.3% |
| Q1 2019 | $5,519,000 | +43.5% | 5,395,000 | +39.5% | 0.00% | 0.0% |
| Q4 2018 | $3,845,000 | -77.9% | 3,868,000 | -76.3% | 0.00% | -40.0% |
| Q3 2018 | $17,414,000 | -8.0% | 16,340,000 | -12.8% | 0.01% | 0.0% |
| Q2 2018 | $18,931,000 | +217.6% | 18,740,000 | +195.1% | 0.01% | +66.7% |
| Q1 2018 | $5,960,000 | -24.8% | 6,351,000 | -20.2% | 0.00% | -40.0% |
| Q4 2017 | $7,925,000 | +143.1% | 7,956,000 | +147.2% | 0.01% | +150.0% |
| Q3 2017 | $3,260,000 | – | 3,218,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 53,670 | $57,726,000 | 3.34% |
| SHENKMAN CAPITAL MANAGEMENT INC | 26,959,000 | $29,149,000 | 3.04% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 84,134,000 | $90,539,000 | 1.93% |
| Cheyne Capital Management (UK) LLP | 3,220,000 | $3,452,000 | 1.75% |
| PFM Health Sciences, LP | 40,300,000 | $43,210,000 | 1.52% |
| Sonora Investment Management, LLC | 6,370,000 | $6,807,000 | 0.56% |
| MACKAY SHIELDS LLC | 66,018,000 | $70,980,000 | 0.49% |
| ZAZOVE ASSOCIATES LLC | 1,500,000 | $1,608,000 | 0.20% |
| IRON Financial LLC | 275,000 | $295,000 | 0.15% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,000,000 | $3,216,000 | 0.08% |